466 filings
Page 11 of 24
8-K
f4oagwd74vpzfq
18 Apr 18
Regulation FD Disclosure
12:00am
8-K
uv5h57hs5 c6z56
8 Feb 18
Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial
12:00am
8-K
iy6fy4fm
19 Jan 18
Regulation FD Disclosure
12:00am
8-K
vpao3
4 Jan 18
Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer
12:00am
8-K
5efgls3
21 Dec 17
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
zyy9nx0g
12 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
aulmyx46 ole9
17 Oct 17
Other Events
12:00am
424B5
g7g4w
17 Oct 17
Prospectus supplement for primary offering
12:00am
8-K
grpfq
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
o177yg
1 Sep 17
Rexahn Pharmaceuticals Announces Retirement of its Founder, Chang Ahn, Ph.D., from the Board of Directors
12:00am
EFFECT
wwk6xjkk
11 Jul 17
Notice of effectiveness
12:00am
CORRESP
lmyo8au9k
7 Jul 17
Correspondence with SEC
12:00am
8-K
hlt7j10lu2
12 Jun 17
Other Events
12:00am